DioGenix Raises $1.5M for Clinical Trial of MS Test
December 18, 2012
DioGenix Raises $1.5M for Clinical Trial of MS Test
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- With $1.5M in New Financing, DioGenix Starts Prospective Trial of Targeted Sequencing-based MS Test
January 2, 2013 / Clinical Sequencing News - DioGenix, Fast Forward Partner on NGS-based MDx for MS
November 8, 2012 / GenomeWeb Daily News - Foundation Medicine Raises More Funds in Series A Round
October 18, 2011 / GenomeWeb Daily News - Foundation Medicine Raises $10M, Targeting $20.5M
August 24, 2011 / GenomeWeb Daily News - Myriad to Replace BRACAnalysis, Other Hereditary Cancer Tests with MyRisk Panel
May 9, 2013 / GenomeWeb Daily News